Researchers sought to determine the optimal dosing for venetoclax in combination with ibrutinib for patients with relapsed or refractory MCL.
Researchers sought to determine whether adding uproleselan to chemotherapy would have clinical impact in treating patients with AML.
Researchers sought to determine whether loss of MRD bone marrow negativity after ASCT could predict relapse in patients with multiple myeloma.
Researchers sought to determine the incidence of fatal and nonfatal CVD during 5 years of follow up in adults with hemophilia.
Researchers sought to determine whether adding venetoclax to R-EPOCH would induce durable responses in patients with Richter syndrome.
Researchers sought to determine whether interferon-alpha or hydroxyurea would be effective treatments for patients with essential thrombocythemia and polycythemia vera.
Researchers sought to determine the dose and safety profile for mosunetuzumab administered for patients with aggressive and indolent relapsed or refractory B-NHLs.
Researchers sought to determine whether brentuximab vedotin with bendamustine would be effective in pediatric patients with relapsed or refractory Hodgkin lymphoma.
Researchers sought to determine whether differing oxidative stress response capabilities in patients with MF could be a mechanism underlying disease progression.
Researchers sought to determine whether there is an association between INR and anticoagulation-related outcomes in an Asian population after AVR or MVR.
